Site #226 is a clinical research site located in Seattle, Washington, United States 98105.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Site #226 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH).
Sponsors: Corcept Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Seattle
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site #226 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site #226 has 1 clinical trials on record, with 1 currently active. Their work covers Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH).
Site #226 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.